TTD | Drug: D03OYD

Drug General Information
Drug ID	D03OYD
Former ID	DIB018474
Drug Name	13,14-dihydro-16-m-chlorophenoxy-w-tetranor-PGF1alpha
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[539252]
Structure		Download 2D MOL
Formula	C22H33ClO6
InChI	InChI=1S/C22H33ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h5-7,12,16,18-21,24-26H,1-4,8-11,13-14H2,(H,27,28)/t16-,18-,19-,20+,21-/m1/s1
InChIKey	XECZBZWECQIBDA-LELZANKISA-N
PubChem Compound ID	5311240
PubChem Substance ID	7979769, 15056658, 39340948, 50957595, 103214704, 103985321, 114155643, 129675921, 135649649, 140326510
Target and Pathway
Target(s)	Prostaglandin F2-alpha receptor	Target Info	Agonist	[525721]
KEGG Pathway	Calcium signaling pathway
KEGG Pathway	Neuroactive ligand-receptor interaction
Reactome	Prostanoid ligand receptors
Reactome	G alpha (q) signalling events
WikiPathways	Prostaglandin Synthesis and Regulation
	GPCRs, Class A Rhodopsin-like
	Gastrin-CREB signalling pathway via PKC and MAPK
	Small Ligand GPCRs
	GPCR ligand binding
	GPCR downstream signaling
	GPCRs, Other
References
Ref 539252	(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1955).
Ref 525721	J Med Chem. 2000 Mar 9;43(5):945-52.Design and synthesis of 13,14-dihydro prostaglandin F(1alpha) analogues as potent and selective ligands for the human FP receptor.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information